Clinical Trial

KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma)

Name: KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma) — clinical trial record (NCT07596693)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KXV01 TCR Lentinvivo for patients with advanced solid tumors.

Trial Details

NCT Number	NCT07596693
Lead Sponsor	TCRx Therapeutics Co.Ltd Collaborators: Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Conditions	Advanced Solid Tumors
Enrollment	30 participants
Start Date	2025-12-19
Primary Completion	2027-12-31 (estimated)
Study Completion	2029-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-19